Suppr超能文献

COVID-19 对时间敏感的 STEMI 治疗的影响:来自北美震中地区的报告。

Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter.

机构信息

Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; Centre Hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, Québec, Canada.

Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; Centre Hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, Québec, Canada; Cité-de-la-Santé Hospital, Laval, Québec, Canada.

出版信息

Cardiovasc Revasc Med. 2021 Sep;30:33-37. doi: 10.1016/j.carrev.2020.09.024. Epub 2020 Sep 19.

Abstract

BACKGROUND

Coronavirus disease 2019 (COVID-19) has forced dramatic changes to the healthcare systems throughout the world. Time-sensitive management of cardiovascular emergencies such as ST-elevation myocardial infarction (STEMI) has yet to be evaluated in the context of these new policies, particularly in so-called "hot spot" cities.

METHODS

We evaluated the early impact of the pandemic on STEMI performance in the Greater Montreal Area. A total of 167 patients from 3 different study periods were included. Patients presenting in the lockdown period from mid-March to mid-May 2020 (Group C, 53 patients) were compared to those from mid-March to mid-May 2019 (Group A, 60 patients) and the 2020 pre-COVID-19 period (Group B, 54 patients).

RESULTS

The number of STEMI admissions was unaffected during the lockdown. However, significantly longer delays between symptom onset and first medical contact (FMC) were noted (Group C 189.0 IQR [70.0, 840.0] min vs. Group A 103.0 IQR [42.5, 263.0] min vs. Group B 91.0 IQR [38.0, 235.5 min], P = 0.007). In contrast, additional safety protocols do not appear to have significantly affected delays between FMC and first intracoronary device activation (Group C 102 IQR [73.0, 133.0] min vs. Group A 104 IQR [87.0, 146.0] min vs. Group B 99.5 IQR [80.0, 150.0] min, P = 0.37). Patients that presented during the outbreak were more likely to be unstable with a higher incidence of Killip classes II-IV compared to groups A and B (28.3% vs. 18.3% vs. 5.6% respectively, P = 0.008). Worse in-hospital outcomes were also noted with a significantly higher rate of major adverse cardiac events (Group A 5.0% vs. Group B 11.1% vs. Group C 22.6%, P = 0.007).

CONCLUSION

During the lockdown period, many patients appear to have been reluctant to present to hospitals. This was associated with more unstable STEMI presentations and worse in-hospital course. Importantly, the health care system appears able to ensure timely acute cardiac care while ensuring that COVID-19 protocols are respected.

摘要

背景

2019 年冠状病毒病(COVID-19)迫使全球医疗系统发生了重大变化。心血管急症的时间敏感管理,如 ST 段抬高型心肌梗死(STEMI),尚未在这些新政策背景下进行评估,特别是在所谓的“热点”城市。

方法

我们评估了大蒙特利尔地区大流行对 STEMI 表现的早期影响。总共纳入了来自 3 个不同研究期的 167 名患者。与 2019 年 3 月至 5 月中旬(组 A,60 名患者)和 2020 年 COVID-19 前(组 B,54 名患者)相比,在 2020 年 3 月至 5 月中旬的封锁期间就诊的患者(组 C,53 名患者)。

结果

封锁期间 STEMI 入院人数没有增加。然而,首次医疗接触(FMC)前的时间明显延长(组 C 189.0 IQR [70.0, 840.0] min vs. 组 A 103.0 IQR [42.5, 263.0] min vs. 组 B 91.0 IQR [38.0, 235.5 min],P=0.007)。相比之下,额外的安全协议似乎并没有显著影响 FMC 和首次经皮冠状动脉介入治疗设备激活之间的时间延迟(组 C 102 IQR [73.0, 133.0] min vs. 组 A 104 IQR [87.0, 146.0] min vs. 组 B 99.5 IQR [80.0, 150.0] min,P=0.37)。与组 A 和 B 相比,在疫情期间就诊的患者更不稳定,Killip 分级 II-IV 的发生率更高(分别为 28.3%、18.3%和 5.6%,P=0.008)。住院期间也出现了更差的结果,主要不良心脏事件的发生率显著更高(组 A 5.0%,组 B 11.1%,组 C 22.6%,P=0.007)。

结论

在封锁期间,许多患者似乎不愿意去医院就诊。这与更不稳定的 STEMI 表现和更差的住院病程有关。重要的是,医疗保健系统似乎能够确保及时进行急性心脏护理,同时确保遵守 COVID-19 协议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60c3/7501080/24d410c20793/gr1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验